Antibiotics need a special place in the drug pricing debate

Antibiotics need a special place in the drug pricing debate

Do you think their plans for these drugs were doomed from the start, or was their execution poor? How might they have made it to market? For antibiotic companies, is it a macro matter of market size and reimbursement rates, or a more manageable business problem of sales/strategy/tactics?



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More